1. Home
  2. SRRK vs NAD Comparison

SRRK vs NAD Comparison

Compare SRRK & NAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • NAD
  • Stock Information
  • Founded
  • SRRK 2012
  • NAD 1999
  • Country
  • SRRK United States
  • NAD United States
  • Employees
  • SRRK N/A
  • NAD N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • NAD Investment Managers
  • Sector
  • SRRK Health Care
  • NAD Finance
  • Exchange
  • SRRK Nasdaq
  • NAD Nasdaq
  • Market Cap
  • SRRK 3.2B
  • NAD 2.6B
  • IPO Year
  • SRRK 2018
  • NAD N/A
  • Fundamental
  • Price
  • SRRK $36.36
  • NAD $11.21
  • Analyst Decision
  • SRRK Strong Buy
  • NAD
  • Analyst Count
  • SRRK 7
  • NAD 0
  • Target Price
  • SRRK $42.17
  • NAD N/A
  • AVG Volume (30 Days)
  • SRRK 1.2M
  • NAD 595.7K
  • Earning Date
  • SRRK 08-06-2025
  • NAD 01-01-0001
  • Dividend Yield
  • SRRK N/A
  • NAD 4.35%
  • EPS Growth
  • SRRK N/A
  • NAD N/A
  • EPS
  • SRRK N/A
  • NAD N/A
  • Revenue
  • SRRK N/A
  • NAD N/A
  • Revenue This Year
  • SRRK N/A
  • NAD N/A
  • Revenue Next Year
  • SRRK $1,960.31
  • NAD N/A
  • P/E Ratio
  • SRRK N/A
  • NAD N/A
  • Revenue Growth
  • SRRK N/A
  • NAD N/A
  • 52 Week Low
  • SRRK $6.76
  • NAD $9.56
  • 52 Week High
  • SRRK $46.98
  • NAD $11.64
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 46.15
  • NAD 52.76
  • Support Level
  • SRRK $36.96
  • NAD $11.10
  • Resistance Level
  • SRRK $39.13
  • NAD $11.15
  • Average True Range (ATR)
  • SRRK 1.69
  • NAD 0.07
  • MACD
  • SRRK -0.59
  • NAD 0.00
  • Stochastic Oscillator
  • SRRK 9.08
  • NAD 52.42

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About NAD Nuveen Quality Municipal Income Fund

Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: